250 related articles for article (PubMed ID: 10083158)
1. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
[No Abstract] [Full Text] [Related]
2. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
Daly I; Jain A; Reyes J; Fung J
Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
[No Abstract] [Full Text] [Related]
4. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl TE; Fung JJ
Transplant Proc; 2001; 33(1-2):1342-4. PubMed ID: 11267319
[No Abstract] [Full Text] [Related]
5. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1468-9. PubMed ID: 9636596
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation.
Tzakis AG; Weppler D; Khan MF; Koutouby R; Romero R; Viciana AL; Raskin J; Nery JR; Thompson J
Transplant Proc; 1998 Sep; 30(6):2677-9. PubMed ID: 9745545
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
[No Abstract] [Full Text] [Related]
8. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
[No Abstract] [Full Text] [Related]
9. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
Eckhoff DE; McGuire BM; Frenette LR; Contreras JL; Hudson SL; Bynon JS
Transplantation; 1998 Jan; 65(2):180-7. PubMed ID: 9458011
[TBL] [Abstract][Full Text] [Related]
12. Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation.
Zuckermann A; Birsan T; Thaghavi S; Kupilik N; Deviatko E; Dekan G; Wolner E; Klepetko W
Transplant Proc; 1999; 31(1-2):1160-1. PubMed ID: 10083518
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation.
Glanemann M; Klupp J; Langrehr JM; Platz KP; Schröer G; Raakow R; Stange B; Settmacher U; Bechstein WO; Neuhaus P
Transplant Proc; 2001; 33(1-2):1069-70. PubMed ID: 11267194
[No Abstract] [Full Text] [Related]
14. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
[TBL] [Abstract][Full Text] [Related]
15. Indications for mycofenolate mofetil therapy after liver transplantation.
Platz KP; Mueller AR; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
[No Abstract] [Full Text] [Related]
16. Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients.
Kliem V; Boeck A; Eisenberger U; Petersen R; Radermacher J; Hiss M; Pethig M; Koch KM; Nashan B; Brunkhorst R
Transplant Proc; 1999; 31(1-2):1312-3. PubMed ID: 10083586
[No Abstract] [Full Text] [Related]
17. Experience with neoral cyclosporine through the oral route in liver transplantation.
Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
[No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil rescue therapy in liver transplant recipients.
Gavlik A; Goldberg MG; Tsaroucha A; Webb MG; Khan RT; Weppler D; Nery JR; Khan MF; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997; 29(1-2):549-52. PubMed ID: 9123124
[No Abstract] [Full Text] [Related]
19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
20. Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results.
Hodge EE; Reich DJ; Clavien PA; Kim-Schluger L
Transplant Proc; 2002 Aug; 34(5):1546-7. PubMed ID: 12176477
[No Abstract] [Full Text] [Related]
[Next] [New Search]